daunorubicin has been researched along with gallium in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Carter, SK | 1 |
Elliott, RL; Head, JF; Wang, F | 1 |
Abodo, LO; Baas, J; Frias, C; Frias, J; Jakupec, MA; Keppler, BK; Prokop, A; Wilke, NL | 1 |
1 review(s) available for daunorubicin and gallium
Article | Year |
---|---|
New cytotoxic drugs for breast cancer and their clinical evaluation.
Topics: Altretamine; Aminoacridines; Amsacrine; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Daunorubicin; Doxorubicin; Female; Gallium; Humans; Ifosfamide; Leukemia; Vinblastine; Vindesine; Zinostatin | 1980 |
1 trial(s) available for daunorubicin and gallium
Article | Year |
---|---|
New cytotoxic drugs for breast cancer and their clinical evaluation.
Topics: Altretamine; Aminoacridines; Amsacrine; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Daunorubicin; Doxorubicin; Female; Gallium; Humans; Ifosfamide; Leukemia; Vinblastine; Vindesine; Zinostatin | 1980 |
2 other study(ies) available for daunorubicin and gallium
Article | Year |
---|---|
Antineoplastic drugs that interfere with iron metabolism in cancer cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Division; Cisplatin; Clinical Trials as Topic; Daunorubicin; Deferoxamine; Female; Gallium; Humans; Indium; Iron; Rats; Transferrin; Tumor Cells, Cultured | 1997 |
The gallium complex KP46 sensitizes resistant leukemia cells and overcomes Bcl-2-induced multidrug resistance in lymphoma cells via upregulation of Harakiri and downregulation of XIAP in vitro.
Topics: Apoptosis; Daunorubicin; Down-Regulation; Drug Resistance, Multiple; Gallium; Humans; Leukemia; Lymphoma; Organometallic Compounds; Up-Regulation; X-Linked Inhibitor of Apoptosis Protein | 2022 |